Evotec SE (NAS:EVO)
$ 4.54 -0.34 (-6.97%) Market Cap: 1.61 Bil Enterprise Value: 1.77 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 73/100

Q1 2022 Evotec SE Earnings Call Transcript

May 11, 2022 / 12:00PM GMT
Release Date Price: $10.89 (-13.23%)
Operator

Dear ladies and gentlemen, welcome to the conference call of Evotec SE. At our customers' request, this conference will be recorded. (Operator Instructions)

May I now hand you over to Werner Lanthaler from Evotec, who will lead you through this conference.

Werner Lanthaler
Evotec SE - Chairman of Management Board & CEO

Welcome to our Q1 quarterly call to Evotec. It's great to welcome you on the R&D Autobahn to Cures, where we are landing and expanding and setting the pace for drug discovery and development. We have uploaded a presentation for this call, and you will always find this presentation on our website and now on the web page to follow.

If you go to Page #2 of this presentation, you can see that I'm here together with my team, and I'm especially happy that our new CBO, Matthias Evers, has joined the team and let us warmly welcome him in this crowd as well. I'm here together with Enno, our CFO; our COO, Craig; and our CSO, Cord, who within this call, also bring a bit more color and deeper understanding to the yesterday

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot